New Board Member

PL BioScience announces new Board Member

PL BioScience announces Ole Henrik Bang-Andreasen as the newest Member of the Board

PL BioScience has revealed that Ole Henrik Bang-Andreasen has been appointed to its Board of Directors, following the passing of board member Reinhard Vogt. Ole brings significant experience and leadership expertise, and will be of great value as PL BioScience moves into a new era of accelerated development and expansion. He currently serves as a Principal in the London office of AVANT BIO, where he focuses on advancing healthcare and biotechnology ventures.

“Working with Ole during this board seat transition has been a great pleasure. His deep scientific insight, combined with sharp investment acumen have already been highly beneficial to our team. We are excited to work together further as PL BioScience continues to strengthen its position as a leader in Human Platelet Lysate technology. At the same time, we are deeply saddened by the loss of our colleague, friend and mentor Reinhard Vogt,” said Dr. Hatim Hemeda, CEO of PL BioScience.

“Joining the PL BioScience (PLB) board is bittersweet with the passing of my colleague and mentor Reinhard Vogt. Taking the baton from Reinhard, I am looking forward to helping PLB build the world’s leading HPL company, starting with a new facility in Aachen, and a busy but exciting roadmap ahead,” Ole Henrik Bang-Andreasen added.

In memory of Reinhard Vogt

It is with deep sadness that PL BioScience GmbH shares news of the passing of Reinhard Vogt on September 8, 2025. Reinhard was a dear friend, mentor, and member of our Board of Directors since 2024. Widely respected as a visionary in the life science industry, Reinhard’s experience, kindness, and passion for life sciences inspired everyone around him. We are grateful for his guidance and the time we shared. Our thoughts are with his family and friends at this time.

Read more on this transition here.